Detalhe da pesquisa
1.
Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.
Eur Radiol
; 25(3): 837-49, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249313
2.
Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.
J Cancer Res Clin Oncol
; 132(3): 163-70, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16328436
3.
Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Cancer Res
; 64(1): 189-95, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14729623
4.
Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
Hum Pathol
; 33(6): 632-41, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12152163
5.
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions.
PLoS One
; 8(6): e68252, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826382
6.
Etiology and prognosis of fetal ascites.
Fetal Diagn Ther
; 18(4): 230-6, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12835581
7.
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Cancer
; 97(12): 2978-87, 2003 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12784332
8.
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
Am J Pathol
; 160(3): 893-903, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11891188
9.
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Int J Cancer
; 102(5): 507-13, 2002 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12432554